BioWorld - Sunday, February 23, 2020

Digital health, BioWorld MedTech
%{topic} RSS Feed RSS

tech-body-scan-analysis.png

Q Bio scores $40M in series B, eyes opening additional centers, enhancing digital health platform

February 21, 2020
By Liz Hollis
No Comments
Redwood City, Calif.-based Q Bio Inc., which is offering a quantitative assessment of personal health, has come out of stealth mode, scooping up $40 million in a series B funding round led by Andreessen Horowitz. The funds are earmarked to improve its proprietary platform and technology to make its preventive health services faster, better and more affordable for all.
Read More
Cancer-cells-pic.png

Nantomics’ deep learning algorithm provides fast identification of cancer marker

February 19, 2020
By Mark McCarty
No Comments
Nantomics LLC, of Culver City, Calif., reported that research based on the company’s deep learning system has been published in a peer-reviewed journal, highlighting the algorithm’s ability to discern which mutation drives a patient’s breast cancer. The company said their approach is a rapid and cost-effective way to establish the breast cancer subtype, thus giving clinician and patient alike a good understanding of which therapies would be ineffective for that cancer and maximizing the chances for a cure.
Read More
AI-network-machine-learning.png

Sutter Health sees promise with Ferrum's AI quality platform in preventing medical errors

February 18, 2020
By Liz Hollis
No Comments
Ferrum Health Inc., of San Francisco, is looking to prevent medical errors with the help of artificial intelligence (AI). That caught the eye of Sutter Health, a not-for-profit health care network in Northern California. To that end, the two have unveiled the debut of Ferrum's AI-powered platform as the system to deliver more consistent care to patients.
Read More
2-11-Varian-Ethos.png

Varian receives FDA nod for Ethos therapy

February 11, 2020
By Liz Hollis
No Comments
Palo Alto, Calif.-based Varian Medical Systems Inc. has won the U.S. FDA’s nod for its Ethos therapy, an artificial intelligence (AI)-driven holistic solution that is aiming to transform cancer care. This solution is designed to deliver an entire adaptive treatment in a typical 15-minute slot and is intended to put the patient at the center of care, noted Chris Toth, president of Varian Oncology Systems.
Read More

Popular Stories

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe